Initial Results from a Novel Video Cholangiopancreatoscope: An International Multicenter Study
Authors:
- David M. de JongDJDavid M. de Jong
- Willem J. LammersWLWillem J. Lammers
- Akin IndersonAIAkin Inderson
- Rogier P. VoermansRVRogier P. Voermans
- Jan Werner PoleyJPJan Werner Poley
- George J.M. WebsterGWGeorge J.M. Webster
- Heng ChiHCHeng Chi
- Mark EllrichmannMEMark Ellrichmann
- Jörn Arne MeierJMJörn Arne Meier
- Michael PraktiknjoMPMichael Praktiknjo
- Cecilia BindaCBCecilia Binda
- Carlo FabbriCFCarlo Fabbri
Open Access
- 13 January 2026
- journal article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Abstract
Background Novel 8.9-Fr and 11-Fr digital cholangiopancreatoscopes (Scivita Medical) have recently become available in Europe, but data on technical performance and safety remain limited. We report initial real-world experience with the Scivita platform. Methods This international, multicenter, retrospective cohort study included consecutive patients undergoing digital single-operator cholangioscopy (dSOC) or pancreatoscopy (dSOP) between March and October 2025 at 10 European centers. The primary outcome was technical success, defined as achievement of the intended procedural goal. Secondary outcomes included intra- and post-procedural complications, classified using the AGREE classification. Results In total, 77 patients (54.5% female; median age 70 years [IQR: 60–76]) were included. In 68 patients, 78 dSOC procedures achieved an overall technical success rate of 91% (71/78): choledocholithiasis 87% (33/38), biliary strictures 96% (24/25), selective cannulation 100% (2/2), evaluation of intraductal margins 50% (1/2), and migrated stent removal 100% (1/1). In all, 9 patients underwent 11 dSOP procedures, with an overall technical success rate of 63.6% (7/11): stone clearance 66.7% (4/6), intraductal papillary mucinous neoplasm assessment 50% (1/2), bridging pancreatic duct disruption 0% (0/1). No intraprocedural complications occurred. Postprocedural complications followed six dSOC procedures: cholangitis in two, mild post-ERCP pancreatitis in two, and abdominal pain without a clear substrate in two. One patient developed mild pancreatitis after dSOP. Conclusion Scivita dSOC demonstrated high technical success and an excellent safety profile. Larger prospective studies are warranted to validate these findings and define the role of dSOC and dSOP of Scivita cholangiopancreatoscopy in clinical practice, while also taking into account cost-effectiveness and environmental impact.Keywords
This publication has 14 references indexed in Scilit:
- Fluoroscopy-free direct solitary cholangioscopy versus endoscopic retrograde cholangiography for clearance of noncomplex biliary stones: a noninferiority randomized controlled trialGastrointestinal Endoscopy, 2026
- Clinical practice guideline on the use of single-operator cholangioscopy in the diagnosis of indeterminate biliary stricture and the treatment of difficult biliary stonesSurgical Endoscopy, 2023
- Digital single-operator cholangioscopy to guide selective cannulation of complex biliary stricturesSurgical Endoscopy, 2022
- Cholangioscopy-Guided Surgical Clip Extraction During Giant Stone LithotripsyDigestive Diseases and Sciences, 2022
- Pancreatoscopy-guided electrohydraulic lithotripsy for the treatment of obstructive pancreatic duct stones: a prospective consecutive case seriesGastrointestinal Endoscopy, 2022
- Consensus guidelines on the role of cholangioscopy to diagnose indeterminate biliary strictureHPB, 2022
- Cholangioscopy-guided removal of a proximally migrated biliary stent using a modified standard polypectomy snareVideoGIE, 2021
- Diagnostic performance of digital and video cholangioscopes in patients with suspected malignant biliary strictures: a systematic review and meta-analysisSurgical Endoscopy, 2021
- Randomized trial of cholangioscopy-guided laser lithotripsy versus conventional therapy for large bile duct stones (with videos)Gastrointestinal Endoscopy, 2018
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007